We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AWH
326
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $8.91M | 0.07% |
253,688
-7,822
| -3% | -$282K |
|
327
ASE Group
ASX
$76.3B
| $8.82M | 0.07% |
1,579,881
-212,705
| -12% | -$1.12M |
|
328
Roper Technologies
ROP
$38.5B
| $8.8M | 0.07% |
51,610
+13,828
| +37% | +$2.42M |
|
329
Fidelity National Information Services
FIS
$23.8B
| $8.76M | 0.07% |
118,906
-378
| -0.3% | -$26.6K |
|
330
Banco Bradesco
BBD
$37.9B
| $8.71M | 0.07% |
2,154,835
-177,014
| -8% | -$652K |
|
331
Cardinal Health
CAH
$53.2B
| $8.7M | 0.07% |
111,557
-19,392
| -15% | -$1.55M |
|
332
Avnet
AVT
$7.12B
| $8.69M | 0.07% |
214,530
-60,687
| -22% | -$2.53M |
|
|
BCR
333
DELISTED
CR Bard Inc.
BCR
| $8.59M | 0.07% |
36,528
+1,593
| +5% | +$346K |
|
334
Grupo Cibest SA
CIB
$22.3B
| $8.57M | 0.07% |
245,294
+113,556
| +86% | +$4.02M |
|
335
Newell Brands
NWL
$2.18B
| $8.55M | 0.07% |
176,039
+77,890
| +79% | +$3.64M |
|
336
International Paper
IP
$22.8B
| $8.47M | 0.07% |
211,013
+11,191
| +6% | +$445K |
|
|
SJR
337
DELISTED
Shaw Communications Inc.
SJR
| $8.46M | 0.07% |
440,613
+115,108
| +35% | +$2.18M |
|
338
VF Corp
VFC
$5.87B
| $8.44M | 0.07% |
145,752
+23,811
| +20% | +$1.41M |
|
|
IM
339
DELISTED
Ingram Micro
IM
| $8.33M | 0.07% |
239,532
+45,612
| +24% | +$1.59M |
|
|
CUK
340
DELISTED
Carnival PLC
CUK
| $8.29M | 0.06% |
184,967
-1,000
| -0.5% | -$50.6K |
|
341
Regeneron Pharmaceuticals
REGN
$77.4B
| $8.25M | 0.06% |
23,613
+2,414
| +11% | +$930K |
|
342
Moody's
MCO
$83.5B
| $8.23M | 0.06% |
87,867
+5,625
| +7% | +$544K |
|
343
Banco de Chile
BCH
$21.3B
| $8.23M | 0.06% |
412,942
+75,794
| +22% | +$1.48M |
|
|
MSGN
344
DELISTED
MSG Networks Inc.
MSGN
| $8.21M | 0.06% |
535,351
+242,314
| +83% | +$4.08M |
|
|
ALXN
345
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.2M | 0.06% |
70,190
+7,569
| +12% | +$1.07M |
|
346
Annaly Capital Management
NLY
$17.3B
| $8.16M | 0.06% |
184,201
+18,123
| +11% | +$771K |
|
347
Conagra Brands
CAG
$7.19B
| $8.13M | 0.06% |
218,557
+13,373
| +7% | +$477K |
|
348
Canadian Natural Resources
CNQ
$98.6B
| $8.12M | 0.06% |
537,742
+11,309
| +2% | +$160K |
|
|
STJ
349
DELISTED
St Jude Medical
STJ
| $8.1M | 0.06% |
103,829
+25,027
| +32% | +$1.78M |
|
|
PXD
350
DELISTED
Pioneer Natural Resource Co.
PXD
| $8.03M | 0.06% |
53,126
+4,625
| +10% | +$726K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.